Search

Contact Us

Author: admin

Published by

Integral Molecular Enables Rapid Resistance Testing of Vaccines and Drugs Against Emerging Coronavirus Variants

PHILADELPHIA — In response to the evolving COVID-19 pandemic, Integral Molecular has adapted its SARS-CoV-2 reporter virus particle (RVP) technology to reflect emerging virus […]

Read More

Published by

Integral Molecular Announces Best-in-Class Antibodies Against Complex Oncology Target Claudin 18.2

PHILADELPHIA – Integral Molecular, the leader in discovering antibodies against multipass membrane proteins, announces fully optimized, high-affinity lead monoclonal antibodies (MAbs) against Claudin 18.2 […]

Read More

Published by

Integral Molecular Partners with China’s Leading Preclinical CRO JOINN for Comprehensive Specificity Testing of Antibodies and CAR-T Therapeutics

PHILADELPHIA – JOINN Laboratories, China’s leading preclinical contract research organization (CRO), has partnered with Integral Molecular to provide researchers in China with rapid antibody […]

Read More

Published by

Virology – SARS-CoV-2 RVPs and Live Virus Show Similar Neutralization Titers

Integral Molecular In response to the COVID-19 pandemic, researchers at the University of Pittsburgh raised a panel of high-affinity SARS-CoV-2 nanobodies. Read More […]

Read More

Published by

Live Tutorial: 6 Steps to Success in Discovering Monoclonal Antibodies Against Multipass Membrane Proteins

Thursday, October 29, 2020 Watch video Integral Molecular has a 95% success rate of discovering high-affinity monoclonal antibodies against multipass membrane proteins despite the […]

Read More

Published by

Totient Leverages Integral Molecular’s Membrane Proteome Array to Advance Cancer Therapeutic Discovery

PHILADELPHIA – Integral Molecular and Totient announce a partnership leveraging Integral Molecular’s Membrane Proteome Array (MPA) target identification technology to advance the discovery of […]

Read More

Published by

Integral Molecular Awarded Grant from the Commonwealth of Pennsylvania to Advance COVID-19 Research

PHILADELPHIA – Integral Molecular has been awarded $521,723 from the Commonwealth of Pennsylvania to leverage its technologies in the global fight against COVID-19. Integral […]

Read More

Published by

Integral Molecular & Fierce Bio Present: De-risk Antibody and CAR-T Safety by Identifying Off-target Specificity Webinar

The long-held assumption that antibodies are exquisitely specific is being re-examined since 25% of monoclonal antibodies (MAbs) show polyspecificity and bind unintended targets. This […]

Read More

Published by

Humanized Chicken Antibody Technology to Drive Next Generation of Integral Molecular’s MPS Antibody Discovery Platform

PHILADELPHIA – Integral Molecular announces the development of Humanized Chicken Antibody Technology (hCAT) and the incorporation of hCAT into the company’s industry-leading MPS antibody […]

Read More

Search